Literature DB >> 28702776

Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice.

Pasquale Niscola1, Andrea Tendas2, Elisabetta Abruzzese2, Tommaso Caravita2, Luca Cupelli2, Marco Giovannini2, Laura Scaramucci2, Agostina Siniscalchi2, Monika Malgorzata Trawinska2, Paolo de Fabritiis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28702776     DOI： 10.1007/s00277-017-3064-0

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  1 in total

1.  Real-world data on efficacy and safety of azacitidine therapy in chronic myelomonocytic leukemia in China: results from a multicenter, retrospective study.

Authors:  Yu Xu; Rong Guo; Miao Miao; Guangsen Zhang; Jianping Lan; Jie Jin
Journal:  Invest New Drugs       Date:  2022-07-14       Impact factor: 3.651
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.